Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 47: 1839-1841, 2001;
This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Voortman, A.
Right arrow Articles by Verhoef, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Voortman, A.
Right arrow Articles by Verhoef, P.
Related Collections
Right arrow General Clinical Chemistry
Right arrow Lipids, Lipoproteins, and Cardiovascular Risk Factors
(Clinical Chemistry. 2001;47:1839-1841.)
© 2001 American Association for Clinical Chemistry, Inc.


Technical Briefs

Optimal Time Interval between Repeated Blood Sampling for Measurements of Total Homocysteine in Healthy Individuals

Annemarie Voortman1, Alida Melse-Boonstra1,2, Johanna M. Schulz1, Jan Burema1, Martijn B. Katan1,2 and Petra Verhoef1,2a

1 Division of Human Nutrition and Epidemiology, Wageningen University, 6700 EV Wageningen, The Netherlands

2 Wageningen Centre for Food Sciences, 6703 GW Wageningen, The Netherlands

aaddress correspondence to this author at: Wageningen Centre for Food Sciences/Division of Human Nutrition and Epidemiology, Wageningen University, PO Box 8129, 6700 EV Wageningen, The Netherlands; fax 31-317-485369, e-mail Petra.Verhoef{at}Staff.NutEpi.WAU.nl

Many studies have shown that increased plasma concentrations of total homocysteine (tHcy) are associated with cardiovascular disease (1). Like most biological variables, plasma tHcy fluctuates within an individual around a long-term mean (2)(3). tHcy measurements often are based on a single blood sample. Taking the mean of two or more repeated measurements will reduce the error attributable to within-subject biological fluctuations and reflect more closely a person’s true mean tHcy value within a certain period. However, as the time interval between two repeated measurements becomes shorter, the values become more similar and the error reduction diminishes. In that case, the benefit of taking the mean of two measurements is not fully used. On the other hand, intervals that are too long (several weeks) may compromise the compliance of study participants and allow long-term seasonal changes (4)(5).

Several studies on the weekly and monthly biological variation, as expressed by the CV, in plasma tHcy concentrations have been published (Table 1 ). From these studies, no conclusions can be drawn about the optimal time interval between two repeated samples to obtain a sufficiently precise estimate of the true tHcy concentration within a predefined period. The optimal time interval is reached when the interval-specific CV does not increase further with increasing time intervals.


View this table:
[in this window]
[in a new window]
 
Table 1. Biological variation in plasma tHcy concentrations according to several studies using weekly through monthly sampling strategies.

The aim of this study was to determine how many days between two samplings within 1 week are needed to reach the maximum biological variation in tHcy. Our findings may be useful in studies involving estimates of an individual’s true mean concentration of tHcy.

The participants in this study were six male and nine female healthy volunteers, ages 19–46 years. Use of medication or dietary supplements known to affect Hcy or folate metabolism were contraindications for participation. We applied strict criteria related to folate metabolism because folate is a strong determinant of Hcy metabolism. All individuals screened were eligible. Volunteers agreed to participate by signing an informed consent form. The Medical Ethical Committee of the Wageningen University approved the study.

On 5 sequential days, 5 mL of venous blood was collected between 0800 and 1000 from fasting (9–11 h) volunteers. Each volunteer’s five visits occurred at the same time in the morning on each day. Participants had their blood collected in the same position, sitting or lying down, throughout the study. Samples were collected in EDTA-containing tubes. Plasma was separated within 30 min and stored at -80 °C until analysis.

Plasma tHcy concentrations were measured within 2 weeks after the end of the study on a HPLC with fluorescence detection at our laboratory (6)(7). All samples from one individual were analyzed in duplicate in one analytical run to avoid between-run analytical variation. The within-run analytical CV based on these samples was 4.1%. The between-run CV in this laboratory was known to be 6.0%.

The intercorrelation of tHcy values within individuals over time, i.e., the semivariance, was calculated for intervals of 1, 2, 3, and 4 days. The semivariance, {gamma}(d), is equal to one-half the average squared difference in concentration between any two samples that are d days apart; the sum of the squares is divided by twice the number of pairs available at a specified interval (4). Thus, it is an estimate of the conditional variance of the second measurement, given the outcome of the first one. The formula for this calculation is:

where d denotes the time interval between any two observations, x denotes the measured values (here tHcy concentration), t denotes one point in time, and n is the number of interval pairs in the summation (4)(5). As the value of d increases, the semivariance gradually increases and will ultimately approach the full within-person variance, i.e., both analytical and biological variation. At this point, the measurements are no longer correlated and the shortest time interval is found for which the maximum biological variation in tHcy is reached (4).

If repeated measurements are more correlated when they are taken at short time intervals than when they are far apart, a model such as the one described in the Appendix can be applied. The within-subject correlation coefficient ({rho}) between two consecutive measurements, which is called autocorrelation, affects the variance of sums and differences of two consecutive measurements. For uncorrelated measurements ({rho} = 0), it is a well-known property that the SE becomes smaller by a factor of 1/ = 0.71. On the other hand, if the two measurements are completely correlated, i.e., identical, then there is obviously no reduction of variance at all. By plugging in some selected values of {rho} and {sigma}2 in the model and comparing the resulting curve with the empirical data, we found that values for the autocorrelation in the range of 0.5–0.8 were consistent with the data.

A gradual increase of SD in our data with increasing individual mean values of tHcy measured over 5 consecutive days indicated that the usual assumptions of normality and constant variance were violated. We therefore performed a logarithmic transformation on tHcy. This made it possible to express the variability as a CV. For small to moderate values of the CV, i.e., up to ~20%, the (semi-)variance of 100 x ln(tHcy) provides a fair estimate of the squared CV, as can be derived straightforward from the Taylor series: CV = ). This is the more natural model to use when within-subject SDs are proportional to the mean value of the variable, as appeared to be the case in our data. All statistical analyses were performed with SAS (Ver. 6.12 for Windows).

Three volunteers were not fasting on the first day but completed the rest of the study. Data from these volunteers were reported as missing on the first day. The plasma tHcy concentrations in the 15 volunteers throughout the 5 days were 4.2–20.9 µmol/L with a mean of 9.2 (SD, 2.8) µmol/L.

The relationship between CV and sampling interval is shown in Fig. 1 . The values of the semivariance for the different time intervals of 1, 2, 3, and 4 days, based on ln(tHcy) values and expressed as a CV, were 7.9%, 12%, 13%, and 13%, respectively, with corresponding numbers of observation pairs per interval of 57, 42, 27, and 12, respectively. The CV at the time interval of 0 days refers to the analytical variation for duplicates of a single sample, i.e., the within-run analytical CV, which was 4.1% in our study. As Fig. 1 shows, the CV increased monotonically at a decreasing rate when the interval increased from 0 to 4 days. This confirms that measurements on consecutive days were correlated. Beyond the time interval of 2 days, the CV increased very little.



View larger version (14K):
[in this window]
[in a new window]
 
Figure 1. CV for tHcy concentrations within individuals as a function of time interval between repeat fasting blood collections, in days.

Day 0 refers to the within-run analytical variance for duplicate samples.

Thus, sampling on consecutive days reduces the benefit of taking the mean of two measurements as a means of improving precision. For uncorrelated measurements, the error would be reduced by a factor of 0.71 when duplicate samples are taken. We estimated that the autocorrelation for consecutive days was 0.6 in this study. Therefore, the error was reduced only by a factor = 0.89 for a 1-day interval and 0.83 or 0.78 for a 2- or 3-day interval, respectively. For a 4-day interval, the error was reduced by a factor of 0.75 and thus almost reached the full error reduction of a factor of 0.71 that would be achieved if no autocorrelation were present.

This study showed that the CV calculated from the semivariances of two repeated tHcy measurements increases with an increasing sampling interval of 1–4 days. This implicates the presence of autocorrelation of repeated tHcy measurements on short time intervals. The variation hardly increased between intervals of 2–4 days. We therefore suggest that serial blood measurements of tHcy to assess a person’s true mean average should be made at least 2 days apart.

Thirup and Ekelund (8) also examined the day-to-day variation of plasma tHcy on 5 consecutive days, but calculated only one CV instead of interval-specific CVs. They reported a mean within-subject biological CV of 13% (8). We calculated that the within-subject biological variation in our study was 12% at the 4-day interval, which is close to their finding. Studies that used weekly through monthly sampling strategies found lower values for the biological CV for plasma tHcy (Table 1Up ).

We used the method as described by Rotterdam et al. (5) for assessing the optimal time interval in days between repeated cholesterol measurements. Like these authors, we examined the biological variability as a function of time between repeated blood measurements, expressed as a semivariance. An attractive feature of this approach is that it presents different CVs at various time intervals, rather than just one CV.

Because of the presence of autocorrelation, the extent to which the error of the mean can be reduced increases with the time interval between two repeated tHcy measurements. We found that a 4-day interval yields almost the full benefit that can be achieved without the presence of autocorrelation.

In conclusion, this study shows that when the mean of two repeated tHcy determinations is calculated to enhance precision, the measurements should be taken at least 2 or, even better, 3 or 4 days apart to optimize error reduction.


Appendix 1

If xt is a random variate with E(xt) = µ, Var(xt) = {sigma}2, and Covar(xt, xt+d) = {sigma}2{rho}d for d = 0, 1, 2, ... , then {rho} is called the autocorrelation. For this model, the variance of the sum and the difference of two values are:


Thus it follows that the variance of the average of two measurements is:

and the semivariance is:


Acknowledgments

We thank the volunteers for their participation in the study. We also thank the personnel of the division of Human Nutrition and Epidemiology of the Wageningen University who helped us with the study. We would especially like to thank Professor Clive West for scientific advice. The study was supported by the Wageningen Centre for Food Sciences (WCFS).


References

  1. Ueland PM, Refsum H, Beresford SAA, Vollset SE. The controversy over homocysteine and cardiovascular risk. Am J Clin Nutr 2000;72:324-332.[Abstract/Free Full Text]
  2. Mudd SH, Finkelstein JD, Refsum H, Ueland PM, Malinow MR, Lentz SR, et al. Homocysteine and its disulfide derivatives. Arterioscler Thromb Vasc Biol 2000;20:1704-1706.[Free Full Text]
  3. Refsum H, Ueland PM, Nygård O, Vollset SE. Homocysteine and cardiovascular disease. Annu Rev Med 1998;49:31-62.[Web of Science][Medline] [Order article via Infotrieve]
  4. Choudhury N, Wall PML, Truswell AS. Effect of time between measurements on within-subject variability for total cholesterol and high-density lipoprotein cholesterol in women. Clin Chem 1994;40:710-715.[Abstract/Free Full Text]
  5. Rotterdam EP, Katan MB, Knuiman JT. Importance of time interval between repeated measurements of total or high-density lipoprotein cholesterol when estimating an individual’s baseline concentrations. Clin Chem 1987;33:1913-1915.[Abstract/Free Full Text]
  6. Ubbink JB, Vermaak WJH, Bissbort S. Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum. J Chromatogr 1991;565:441-446.[Web of Science][Medline] [Order article via Infotrieve]
  7. Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A, Allen RH. Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 1993;39:1764-1779.[Abstract]
  8. Thirup P, Ekelund S. Day-to-day, postprandial and orthostatic variation of total plasma homocysteine. Clin Chem 1999;45:1280-1283.[Free Full Text]
  9. Rasmussen K, Møller J, Lyngbak M. Within-person variation of plasma homocysteine and effects of posture and tourniquet application. Clin Chem 1999;45:1850-1855.[Abstract/Free Full Text]
  10. Rossi E, Beilby JP, McQuillan BM, Hung J. Biological variability and reference intervals for total plasma homocysteine. Ann Clin Biochem 1999;36:56-61.
  11. Clarke R, Woodhouse P, Ulvik A, Frost C, Sherliker P, Refsum H, et al. Variability and determinants of total homocysteine concentrations in plasma in an elderly population. Clin Chem 1998;44:102-107.[Abstract/Free Full Text]
  12. Cobbaert C, Arentsen JC, Mulder P, Hoogerbrugge N, Lindemans J. Significance of various parameters derived from biological variability of lipoprotein(a), homocysteine, cysteine, and total antioxidant status. Clin Chem 1997;43:1958-1964.[Abstract/Free Full Text]
  13. Garg UC, Zheng ZJ, Folsom AR, Moyer YS, Tsai MY, McGovern P, et al. Short-term and long-term variability of plasma homocysteine measurement. Clin Chem 1997;43:141-145.[Abstract/Free Full Text]



The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
G. Soletormos, A. Semjonow, P. E.C. Sibley, R. Lamerz, P. H. Petersen, W. Albrecht, P. Bialk, M. Gion, F. Junker, H.-P. Schmid, et al.
Biological Variation of Total Prostate-Specific Antigen: A Survey of Published Estimates and Consequences for Clinical Practice
Clin. Chem., August 1, 2005; 51(8): 1342 - 1351.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. P Hannon-Fletcher, N. C Armstrong, J. M Scott, K. Pentieva, I. Bradbury, M. Ward, J. Strain, A. A Dunn, A. M Molloy, M. A Kerr, et al.
Determining bioavailability of food folates in a controlled intervention study
Am. J. Clinical Nutrition, October 1, 2004; 80(4): 911 - 918.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
A. Melse-Boonstra, C. E West, M. B Katan, F. J Kok, and P. Verhoef
Bioavailability of heptaglutamyl relative to monoglutamyl folic acid in healthy adults
Am. J. Clinical Nutrition, March 1, 2004; 79(3): 424 - 429.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Voortman, A.
Right arrow Articles by Verhoef, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Voortman, A.
Right arrow Articles by Verhoef, P.
Related Collections
Right arrow General Clinical Chemistry
Right arrow Lipids, Lipoproteins, and Cardiovascular Risk Factors


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS